Bharti, Ranbaxy, HUL, Jet Airways: Get brokerage advice on all!

Fri, Mar 30, 2012 at 09:00

| Source:
Share   .   Email   .   Print      

Standard Chartered has a target of Rs 465 for Ranbaxy. The higher growth trajectory in the core business is likely to help core margins expand by 400 bps. Consent decree with the US FDA adds medium-term value, with the potential to normalise US sales.

Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.